Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical ...
A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical ...
A committee of outside clinical trial observers has recommended that Praxis Precision Medicines stop testing its experimental treatment for essential ...
A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a ...
Uganda’s health ministry, with support from the World Health Organization (WHO) and its partners, today launched a vaccine trial against ...
A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis ...
The Administration for Strategic Preparedness and Response (ASPR) announced yesterday that it will give drugmaker Shionogi, Inc, $375 million to ...
Credit: CC0 Public Domain A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in ...
A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first ...
Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite ...
Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.